ReviewActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2026
Sinonasal giant cell tumour. Report of four cases and review of the literature.
Review in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Sinonasal giant cell tumour (SnGCT) is very rarely reported. The aim of the study is to present a series of SnGCT treated with an endoscopic or combined approach and to carry out a review of the literature on this topic. Methods: This case series encompassed the clinical data of all the SnGCT surgically treated with curative intent at two different referral centres, between 2001 and 2024. The information was extrapolated to report epidemiologic and clinical data, surgical approach and follow up. A comprehensive clinical review of the literature was also carried out. Results: Among 4 patients included, 3 were treated with a pure endoscopic resection and remained disease-free at the last follow up, while one was managed with a combined approach, who is alive with disease. From the review we found only 32 cases of SnGCT reported, mostly treated with an open approach. Local recurrence was documented in 12.5% of cases, while distant metastasis in 3%. Conclusions: SnGTC is a benign but locally aggressive neoplasm that can present as a lytic lesion. The clinical behaviour of GCT is unpredictable, and it tends to recur locally and may even metastasise. In the nose and paranasal sinuses it is an exceedingly rare entity, but should be considered in the differential diagnosis with a large variety of histologies. Surgery is the treatment of choice for resectable lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.